OncLive SOSS

January 20, 2021
Joyce A. O'Shaughnessy, MD, Baylor Charles A. Sammons Cancer Center

,
Lisa Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center

,
Vijayakrishna Gadi, MD, University of Illinois College of Medicine

,
William Gradishar, MD, Northwestern Medicine

,
Claudine Isaacs, MD, Lombardi Comprehensive Cancer Center

Related Content:

Peer ExchangeBreast CancerNeoadjuvant HER2+
PARP Inhibitors Remain Key Players in Metastatic Breast Cancer
Margetuximab Approval Augments Emerging Treatment Choices in Breast Cancer
An Autopsy of Breast Cancer Management Amidst the COVID-19 Pandemic
x